SCHEMBL7479229

SCHEMBL7479229

CCCCCCCCCCCC1(N2CCN(CCO)CC2)C(=O)NC(=O)NC1=O

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 10/20 0.44
MMP9 P14780 10/20 0.44
ALDH1A1 P00352 3/20 0.40
TP53 P04637 2/20 0.40
HSD17B10 Q99714 2/20 0.40
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
GAA P10253 1/20 0.39
RAB9A P51151 1/20 0.39
RECQL P46063 1/20 0.38
MMP3 P08254 1/20 0.38
MMP8 P22894 4/20 0.37
MMP13 P45452 4/20 0.37
ADAM17 P78536 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7642313 1.00 MMP2 (0.44) MMP2MMP9ALDH1A1TP53HSD17B10
SCHEMBL7477270 1.00 MMP2 (0.44) MMP2MMP9ALDH1A1TP53HSD17B10
SCHEMBL27489960 1.00 MMP2 (0.44) MMP2MMP9ALDH1A1TP53HSD17B10
Benzene SCHEMBL27569333 0.96 MMP2 (0.47) MMP2MMP9ALDH1A1TP53HSD17B10
Benzene SCHEMBL27569478 0.91 MMP2 (0.49) MMP2MMP9ALDH1A1TP53HSD17B10
SCHEMBL7478115 0.91 MMP2 (0.44) MMP2MMP9ALDH1A1TP53HSD17B10
SCHEMBL7477648 0.87 MMP2 (0.42) MMP2MMP9KMT2AMMP8MMP13
SCHEMBL7482265 0.86 MMP9 (0.42) MMP2MMP9ALDH1A1KMT2ARAB9A
SCHEMBL7480664 0.81 MMP2 (0.43) MMP2MMP9ALDH1A1RAB9AMMP13
SCHEMBL7484255 0.81 MMP2 (0.50) MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1318406-C New barbituric acid derivatives, processes for their prodn. and pharmaceutical agent contg. same BOEHRINGER MANNHEIM GMBH (DE) 2007-05-30 CN disclosed
US-6472396-B1 Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds ROCHE DIAGNOSTICS GMBH (DE) 2002-10-29 US disclosed
EP-0869947-B1 BARBITURIC ACID DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND PHARMACEUTICAL AGENTS CONTAINING THESE COMPOUNDS ROCHE DIAGNOSTICS GMBH (DE) 2002-10-23 EP disclosed
US-6110924-A MATRIX METALLOPROTEASE INHIBITORS ROCHE DIAGNOSTICS GMBH (DE) 2000-08-29 US disclosed
EP-0869947-A1 NEW BARBITURIC ACID DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND PHARMACEUTICAL AGENTS CONTAINING THESE COMPOUNDS Roche Diagnostics GmbH (DE) 1998-10-14 EP disclosed
WO-1997023465-A1 NEW BARBITURIC ACID DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND PHARMACEUTICAL AGENTS CONTAINING THESE COMPOUNDS BOEHRINGER MANNHEIM GMBH (DE) 1997-07-03 WO disclosed